Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2

被引:0
|
作者
N Gammoh
E Isaacson
V Tomaić
D J Jackson
J Doorbar
L Banks
机构
[1] International Centre for Genetic Engineering and Biotechnology,Division of Virology
[2] MRC National Institute for Medical Research,undefined
来源
Oncogene | 2009年 / 28卷
关键词
HPV; E7; centrosomes; pRb;
D O I
暂无
中图分类号
学科分类号
摘要
Human papillomavirus (HPV) E7 is essential in inducing S-phase progression in differentiating epithelial cells. We have previously shown that HPV-16 E7 activity can be controlled by a direct interaction with the viral transcriptional activator E2, thereby inhibiting transforming potential of E7. We have extended these analyses to show that E2 induces a generalized re-localization of E7 within the cell nucleus, one potential consequence of which is the inhibition of E7-induced degradation of pRb. Most importantly, we show that E2 can also inhibit the ability of E7 to induce centrosome abnormalities, thus preventing aberrant mitoses. Taken together, these studies highlight the central importance of E2 in controlling the functions of E7, independently of the ability of E2 to regulate transcription.
引用
收藏
页码:2299 / 2304
页数:5
相关论文
共 50 条
  • [21] Association of the HPV-16 E7 oncoprotein with the cullin 2 ubiquitin ligase complex.
    Huh, Kyungwon
    Harper, Jeffrey Wade
    Munger, Karl
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [22] ANTIBODIES TO HPV-16 E6 AND E7 PROTEINS AS MARKERS FOR HPV-16-ASSOCIATED INVASIVE CERVICAL-CANCER
    MULLER, M
    VISCIDI, RP
    SUN, YP
    GUERRERO, E
    HILL, PM
    SHAH, F
    BOSCH, FX
    MUNOZ, N
    GISSMANN, L
    SHAH, KV
    [J]. VIROLOGY, 1992, 187 (02) : 508 - 514
  • [23] Ribozyme-mediated inhibition of HPV-16 E6/E7 immortalization of human keratinocytes.
    Alvarez, LM
    Cullinan, AE
    Siwkowski, A
    Hampel, A
    DiPaolo, JA
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S37 - S37
  • [24] Nuclear import of HPV-16 E7 occurs via an active transport mechanism
    Cid-Arregui, A
    García, G
    Jacjinovic, M
    zur Hausen, H
    [J]. EUROPEAN JOURNAL OF CELL BIOLOGY, 2005, 84 : 46 - 46
  • [25] CHARACTERIZATION OF FUNCTIONAL HPV-16 E7 PROTEIN PRODUCED IN ESCHERICHIA-COLI
    PATRICK, DR
    ZHANG, K
    DEFEOJONES, D
    VUOCOLO, GR
    MAIGETTER, RZ
    SARDANA, MK
    OLIFF, A
    HEIMBROOK, DC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (10) : 6910 - 6915
  • [26] THE HPV-16 E7 ORF ENCODES A PROTEIN WITH TRANSFORMATION AND TRANSCRIPTIONAL TRANSACTIVATION FUNCTIONS
    PHELPS, WC
    YEE, CL
    MUNGER, K
    HOWLEY, PM
    [J]. FASEB JOURNAL, 1988, 2 (04): : A804 - A804
  • [27] 云南HPV-16型E6、E7基因的突变分析
    张晓琳
    刘峰
    姚月婷
    李亚东
    周竞贤
    易力
    姚宇峰
    俞建昆
    [J]. 微生物学杂志, 2014, 34 (02) : 17 - 23
  • [28] CONSERVATION OF HPV-16 E6/E7 ORF SEQUENCES IN A CERVICAL-CARCINOMA
    CONE, RW
    MINSON, AC
    SMITH, MR
    MCDOUGALL, JK
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1992, 37 (02) : 99 - 107
  • [29] In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma
    Madrigal, M
    Janicek, MF
    Sevin, BU
    Perras, J
    Estape, R
    Penalver, M
    Averette, HE
    [J]. GYNECOLOGIC ONCOLOGY, 1997, 64 (01) : 18 - 25
  • [30] Analysis of oncogenes E6 and E7 variants in 78 women infected with HPV-16
    Coste-Burel, M
    Besse, B
    Papy, K
    Lopes, P
    Laboisse, C
    Imbertmarcille, BM
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S101 - S101